Skip to main content
OpenTrials
Recruiting

NCT Number: NCT04505618

Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease

This study will perform a prospective, longitudinal analysis of clinical and imaging findings from normal controls and subjects with retinal vascular disease to better define the diagnostic imaging criteria that signify change in disease stage. This includes disease progression in early stages of disease or disease regression with appropriate standard-of-care treatment.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–99 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Wilmer Eye Institute

Baltimore, Maryland, 21287, United States

Location status: Recruiting

Location contact

Amir H Kashani, MD, PhD

PRINCIPAL_INVESTIGATOR

Ana Collazo Martinez

CONTACT

[email protected]

410-502-5052

C

CONTACT

About this study

The objective of this study is to perform a prospective, longitudinal analysis of clinical and imaging findings from normal controls and subjects with retinal vascular disease to better define the diagnostic imaging criteria that signify change in disease stage. This includes disease progression in early stages of disease or disease regression with appropriate standard-of-care treatment.

Subjects will be identified from healthy subjects (seen for screening eye exams) and diseased subjects undergoing standard-of-care treatment or screening at eye clinic locations. The study population will include subjects with retinal vascular disease including but not limited to diabetic retinopathy, hypertension, retinal vein/arterial occlusion, and macular degeneration. Subjects who are enrolled will undergo non-invasive, minimal risk, FDA approved diagnostic imaging procedures to identify vascular changes.

The study methods will include retrospective review and collection of clinically approved imaging data that is obtained through standard-of-care methods for subjects who meet inclusion and exclusion criteria. Subjects who are identified in this manner will be asked to participate in a prospective study by each clinical study site.

The study end-points include the correlation of diagnostic imaging findings from Optical Coherence Tomography (OCT) based images with fundus photographs, clinical disease stage and visual acuity.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Exclusion criteria

  • Both subjects with diseases and controls:
  • Children (age<18)
  • Pregnant females
  • Developmentally delayed subjects
  • Subjects unable to provide informed consent
  • Inability to cooperate with tests and study instructions
  • Images with motion artifact or signal strength < 7
  • History of glaucoma
  • History of age-related macular degeneration
  • History of any visually significant eye disease
  • History of proliferative diabetic retinopathy
  • History of any inflammatory disease
  • History of heart disease
  • History of thyroid disease.
  • Additional criteria for controls:
  • History of any type of Diabetes Mellitus
  • History of any type of Hypertension

Treatment and study plan

Swept-Source (SS) OCT Angiography

Device

Non-invasive, minimal risk, ocular imaging study

Other names: SS-OCTA

Spectral-Domain (SD) OCT Angiography

Device

Non-invasive, minimal risk, ocular imaging study

Other names: SD_OCTA

Fundus Imaging

Device

Non-invasive, minimal risk, ocular imaging study

Axial Length Measurement Device

Device

Non-invasive, minimal risk, ocular imaging study

Other names: Intraocular Lens (IOL) Master

Primary outcomes

  1. Correlation of Imaging

    Time frame: 5 years

    Correlation of diagnostic imaging findings (vessel skeleton density) from OCT based images with disease stage

Study contacts

Contact information is provided by the study sponsor or research team.

Amir H Kashani, MD, PhD

CONTACT

[email protected]

410-502-2789

Ana C Martinez, MPH

CONTACT

[email protected]

410-502-2789

Sponsors and collaborators

Lead sponsor

Johns Hopkins University

Other

Collaborators

  • National Eye Institute (NEI)

Registry information

Acronym: OCTA-RVD

Important dates

Study start
2019
Primary completion
2027
Study completion
2027
First posted
Aug 10, 2020
Registry last updated
Jun 17, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.